Recently, at the 6th Future Healthcare 100 Conference, HTDK CEO Teresa Chen was honored with the “2022 Future Healthcare Top 100 · Weilan Award · Annual Innovative Entrepreneur” for her outstanding achievements in the commercialization of high-value medical devices.
The Future Healthcare Top 100 List, jointly launched by VBDATA, VB100, and Eggshell Research Institute, is the first ranking in China focused on innovation in healthcare. Its mission is to identify the true innovators representing the future of healthcare, discovering the core forces driving China’s healthcare industry and highlighting the most innovative and promising companies to promote transformation in the healthcare sector.
HTDK is deeply grateful for this recognition from third-party organizations. The company will continue to leverage its professional, customized, and one-stop commercial services to empower and accelerate the commercialization of innovative medical products in China. Through agile decision-making, progressive business models, and innovative services, HTDK is committed to leading the transformation of high-value medical devices and further advancing the commercialization of healthcare innovations.
HTDK remains focused on exploring and enhancing the accessibility of high-value medical devices in China, with a mission to serve global medical device brands and boost the availability of cutting-edge healthcare technologies. The company actively seeks to partner with overseas companies that possess approved innovative medical devices but have yet to enter the Chinese market, helping them secure regulatory approvals and unlock future commercial opportunities. Through its extensive capabilities, HTDK connects patients with trusted medical devices, providing quality healthcare solutions for the Chinese market.
Currently, HTDK has established strategic partnerships with a range of innovative high-value medical device brands. At the 4th China International Import Expo (CIIE) in 2021, HTDK showcased innovative products such as MINIBOX+, the world’s first integrated pulmonary function testing device for measuring lung volume, capacity, and gas diffusion. The device garnered widespread attention from professionals in the field.
During a media interview, Teresa Chen emphasized: “For a long time, domestic medical devices have been predominantly low to mid-range, with a fragmented competitive landscape. While the pharmaceutical sector has seen many licensing introductions, the medical device field is just beginning. In recent years, significant advancements in the innovation of medical devices have been driven by both independent R&D and overseas introductions. We are optimistic about overseas innovation in medical devices. We are uniquely positioned to enhance healthcare accessibility and meet unmet needs through our top-tier registration, import/export, supply chain, and data platforms. Our comprehensive commercial capabilities and diversified product portfolio will enable us to better serve patients and clients. In the future, we will continue to explore areas such as blood glucose monitoring and portable home dialysis equipment. Strategic partnerships in these fields are critical to improving healthcare accessibility and will have a lasting positive impact on patients, families, and communities across China.”
HTDK’s innovative digital channel management services have disrupted traditional medical device distribution models. Managing diverse sales channels, particularly distributors and hospitals, requires significant resources to establish organizational structures, medical expertise, and management capabilities. As a one-stop nationwide commercial solutions provider, HTDK has built a comprehensive distribution network by working with high-quality regional distributors to manage and streamline the process.
Teresa Chen highlighted: “Medical devices are highly regulated and sensitive to storage and transport conditions such as temperature and humidity. Ensuring timely delivery is a challenge. Our channel management solutions focus on improving the efficiency, productivity, and stability of sales networks while enabling accurate information flow between customers, distributors, hospitals, and other retail points. We’ve developed a multi-portal electronic order management system that allows real-time tracking and processing of outbound orders, ensuring customers and distributors can monitor each delivery’s status. Additionally, our CMS is connected to the systems of key distributors, enabling us to track sales data in real-time, assess inventory changes, and adjust marketing and sales plans accordingly.”
HTDK is committed to leading digital transformation in the medical device sector by applying advanced IT technologies that provide personalized and professional services. The company has developed a full-process digital platform tailored to specific business scenarios, offering comprehensive data management to enhance operational efficiency and scalability. HTDK’s integrated smart service connects upstream and downstream stakeholders, facilitating seamless business flow and high-efficiency operations.
HTDK’s solutions span the entire business process, from import/export declaration and customs clearance to inventory management, channel management, tendering, and rebate management. The company has also developed general business applications like the electronic order system (for order tracking), WMS (for warehouse management), TMS (for delivery and product tracking), and CMS (for tracking sales data), integrating clients’ systems with regional distributors to ensure real-time data flow.
As China’s leading cross-border commercial solutions platform, HTDK provides end-to-end services for high-value medical devices across various specialties. The process of entering the Chinese market can be complex for global brands due to language barriers, regulatory restrictions, cultural differences, and infrastructure challenges. With its vast experience, HTDK helps clients navigate these obstacles, reducing complexity and cost. The company’s services cover product registration, import/export, warehousing, distribution, and after-sales management, offering customized solutions to address the challenges global brands face when entering the Chinese market.
HTDK’s extensive expertise, cutting-edge supply chain capabilities, and commitment to excellence have made it the trusted partner for global medical brands like MicroVention, Illumina, Smith & Nephew, and Roche, among others. HTDK continues to set the standard for high-value medical devices across multiple specialties, including ophthalmology, in vitro diagnostics, orthopedics, cardiology, neurology, and respiratory care.